Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and.
Weekly tirzepatide injections in adults with type 2 diabetes and overweight or obesity safely produced a 12.8%-14.7% weight loss after 72 weeks in the SURMOUNT-2 pivotal trial.